SIGA Technologies Inc (SIGA)
6.31
-0.30
(-4.61%)
USD |
NASDAQ |
Nov 14, 16:00
6.25
-0.06
(-0.95%)
After-Hours: 17:51
SIGA Technologies Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2011 | 5.170M |
| June 30, 2011 | 3.835M |
| March 31, 2011 | 3.566M |
| December 31, 2010 | |
| September 30, 2010 | 7.420M |
| June 30, 2010 | 4.93M |
| March 31, 2010 | 5.827M |
| December 31, 2009 | 5.185M |
| September 30, 2009 | 4.828M |
| June 30, 2009 | 4.713M |
| March 31, 2009 | 2.697M |
| December 31, 2008 | 3.423M |
| September 30, 2008 | 2.854M |
| June 30, 2008 | 2.500M |
| March 31, 2008 | 2.836M |
| December 31, 2007 | 2.749M |
| September 30, 2007 | 2.342M |
| June 30, 2007 | 2.201M |
| March 31, 2007 | 2.650M |
| December 31, 2006 | 2.904M |
| September 30, 2006 | 2.156M |
| June 30, 2006 | 2.432M |
| March 31, 2006 | 1.658M |
| December 31, 2005 | 2.396M |
| September 30, 2005 | 1.765M |
| Date | Value |
|---|---|
| June 30, 2005 | 2.583M |
| March 31, 2005 | 1.552M |
| December 31, 2004 | 1.293M |
| September 30, 2004 | 0.8268M |
| June 30, 2004 | 1.026M |
| March 31, 2004 | 1.020M |
| December 31, 2003 | 0.8217M |
| September 30, 2003 | 1.001M |
| June 30, 2003 | 0.6427M |
| March 31, 2003 | 0.4775M |
| December 31, 2002 | 0.5719M |
| September 30, 2002 | 0.4239M |
| June 30, 2002 | 0.4136M |
| March 31, 2002 | 0.357M |
| December 31, 2001 | 0.3759M |
| September 30, 2001 | 0.4977M |
| June 30, 2001 | 0.4289M |
| March 31, 2001 | 0.4306M |
| December 31, 2000 | 0.5782M |
| September 30, 2000 | 0.8761M |
| June 30, 2000 | 0.3917M |
| March 31, 2000 | 0.7629M |
| December 31, 1999 | 0.10M |
| September 30, 1999 | 0.50M |
| June 30, 1999 | 0.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 32.70M |
| Geovax Labs Inc | 4.277M |
| Abbott Laboratories | 713.00M |
| Tonix Pharmaceuticals Holding Corp | 9.698M |
| Chimerix Inc | 18.43M |